Pdt Partners, LLC 4 D Molecular Therapeutics, Inc. Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$20.93 - $30.01 $434,674 - $623,247	-20,768 Reduced 34.54%	39,356 $826,000
Q1 2024 May 15, 2024	BUY	$17.03 - $35.87 $1.02 Million - $2.16 Million	60,124 New	60,124 $1.92 Million
Q1 2023 May 15, 2023	SELL	$15.45 - $23.19 $154,608 - $232,062	-10,007 Reduced 48.11%	10,795 $185,000
Q4 2022 Feb 14, 2023	BUY	$6.85 - $25.46 $14,268 - $53,033	2,083 Added 11.13%	20,802 $462,000
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.48 $130,284 - $214,894	18,719 New	18,719 $151,000

144

57.7M

137K

111K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $234M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.